Related Experiment Video
Updated: Sep 24, 2025

10:44
Snap Chip for Cross-reactivity-free and Spotter-free Multiplexed Sandwich Immunoassays
Published on: November 13, 2017
6.6K
Production of high-complexity frameshift neoantigen peptide microarrays
Luhui Shen1, Zhan-Gong Zhao1, John C Lainson1
1Center for Innovations in Medicine, Biodesign Institute, Arizona State University Tempe AZ USA chris.diehnelt@asu.edu stephen.johnston@asu.edu.
RSC Advances
|May 6, 2022
Summary
This study presents a novel peptide microarray capable of synthesizing over 300 million frameshift neoantigens. This technology enables efficient profiling of patient-specific antibodies against these neoantigens in a single assay.
Area of Science:
- Biotechnology
- Immunology
- Proteomics
Background:
- Peptide microarray technologies facilitate the parallel measurement of numerous antigen-antibody interactions.
- Profiling patient-specific antibodies against neoantigens is crucial for understanding immune responses.
Purpose of the Study:
- To develop and demonstrate a novel peptide microarray system for synthesizing and analyzing a large number of frameshift neoantigens.
- To profile patient-specific antibodies reactive to frameshift neoantigens in a single assay.
Main Methods:
- Utilized mask-based photolithographic peptide synthesis for *in situ* synthesis of over 400,000 frameshift neoantigens.
- Developed a system producing 208 replicate microarrays per wafer, enabling simultaneous synthesis of over 300 million peptides.
- Demonstrated detection of peripheral-blood antibody binding to frameshift neoantigens across multiple synthetic lots.
Main Results:
- Successfully synthesized >400,000 unique frameshift neoantigens on a single peptide microarray.
- The system demonstrated feasibility in detecting peripheral-blood antibody binding to these neoantigens.
- High-throughput synthesis capability of over 300 million peptides simultaneously was achieved.
Conclusions:
- The developed peptide microarray system is a feasible and powerful tool for profiling patient-specific antibodies against a vast array of frameshift neoantigens.
- This technology offers a high-throughput solution for immunological studies and potential diagnostic applications.
- The system's scalability supports routine synthesis for large-scale neoantigen antibody profiling.

